Skye Bioscience, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Warrants and Derivative Liabilities (Details 3)

Warrants and Derivative Liabilities (Details 3) - Monte Carlo simulations - Emerald Financing	Sep. 30, 2019 $ / shares	Dec. 31, 2018 $ / shares	Feb. 16, 2018 $ / shares	Jan. 19, 2018 $ / shares
Class of Warrant or Right [Line Items]
Underlying common stock price	$ 0.37	$ 0.40
Minimum
Class of Warrant or Right [Line Items]
Underlying common stock price			$ 0.29	$ 0.29
Maximum
Class of Warrant or Right [Line Items]
Underlying common stock price			$ 0.30	$ 0.30
Dividend yield
Class of Warrant or Right [Line Items]
Warrants and rights outstanding measurement input	0.0000	0.0000	0.0000	0.0000
Volatility factor
Class of Warrant or Right [Line Items]
Warrants and rights outstanding measurement input			0.700	0.700
Volatility factor \| Minimum
Class of Warrant or Right [Line Items]
Warrants and rights outstanding measurement input	0.819	0.921
Volatility factor \| Maximum
Class of Warrant or Right [Line Items]
Warrants and rights outstanding measurement input	0.821	0.924
Risk-free interest rate
Class of Warrant or Right [Line Items]
Warrants and rights outstanding measurement input	0.0156	0.0249
Risk-free interest rate \| Minimum
Class of Warrant or Right [Line Items]
Warrants and rights outstanding measurement input			0.0245	0.0245
Risk-free interest rate \| Maximum
Class of Warrant or Right [Line Items]
Warrants and rights outstanding measurement input			0.0260	0.0260
Expected term (years)
Class of Warrant or Right [Line Items]
Expected Term			5 years	5 years
Expected term (years) \| Minimum
Class of Warrant or Right [Line Items]
Expected Term	3 years 3 months 21 days	4 years 18 days
Expected term (years) \| Maximum
Class of Warrant or Right [Line Items]
Expected Term	3 years 4 months 17 days	4 years 1 month 17 days